Treatment of HYpertension: Morning Versus Evening
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT02214498
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT02214498
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Unknown status
Technical summary
Registry record NCT02214498. Randomized; quadruple masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2017-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Treatment of HYpertension: Morning Versus Evening
- Acronym
- THYME
- Condition
- Essential Hypertension
- Intervention (Drug)
- Enalapril/hydrochlorothiazide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Erasmus Medical Center
- Collaborator
- ZonMw: The Netherlands Organisation for Health Research and Development
Record details
- Record id
cardio:ct-nct02214498- Content hash
94fe325f1145348f354f366e1390d4f14e4f3934edc490498fc77ae78bf4762b